Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08K Sell
29
-24
-45% -$1.01K ﹤0.01% 1472
2026
Q1
$2.6K Hold
53
﹤0.01% 1344
2025
Q4
$2.81K Buy
53
+17
+47% +$990 ﹤0.01% 1298
2025
Q3
$2.21K Hold
36
﹤0.01% 1286
2025
Q2
$1.92K Hold
36
﹤0.01% 1325
2025
Q1
$1.28K Sell
36
-1
-3% -$37 ﹤0.01% 1358
2024
Q4
$1.29K Buy
37
+1
+3% +$35 ﹤0.01% 1359
2024
Q3
$1.4K Hold
36
﹤0.01% 1288
2024
Q2
$1.28K Hold
36
﹤0.01% 1318
2024
Q1
$1.19K Hold
36
﹤0.01% 1309
2023
Q4
$1.57K Hold
36
﹤0.01% 1303
2023
Q3
$1.65K Buy
+36
New +$1.63K ﹤0.01% 1280

Other funds holding CALX

Central Trust Company's CALX Position: Q2 2026 in Review

Central Trust Company reduced its Calix (CALX) stake by 45% in Q2 2026, selling an estimated $1.01K and leaving 29 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1472.

Central Trust Company first reported a position in CALX in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.81K in Q4 2025. 287 funds tracked by Wall St. Rank hold CALX as of Q2 2026.

  • Central Trust Company held 29 shares of Calix worth $1.08K as of Q2 2026.
  • Central Trust Company sold 24 Calix shares in Q2 2026, an estimated $1.01K.
  • Calix made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1472 holding.
  • Central Trust Company first reported a position in Calix in Q3 2023 and has held it in 12 quarters since.
  • Central Trust Company's Calix position peaked at $2.81K in Q4 2025.
  • 287 funds tracked by Wall St. Rank held Calix as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.